Products

What will AGI do for Amosulalol monohydrochloride?

This classification denotes an adrenergic antagonist with the molecular formula C18H24N2O5S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4O4S698PEE, chemically known as benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, hydrochloride (1:1), but more generally known as amosulalol monohydrochloride, which bears US NIH Compound Identifier 123707. European Medicines Agency schedules amosulalol monohydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05478MIG. Most nations, for tariff purposes, schedule amosulalol monohydrochloride under HS 29350090. SMILES: CC1CCC(CC1S(=O)(=O)N)C(CNCCOC2CCCCC2OC)O.CL.

How AGI delivers it

Four ways AGI delivers for Amosulalol monohydrochloride

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amosulalol monohydrochloride, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amosulalol monohydrochloride, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amosulalol monohydrochloride connects

measured by

  • Assay Puritymodel
  • Chloride Contentmodel
  • Chromatographic Impurity Profilemodel
  • Loss On Dryingmodel
  • Moisture Contentmodel
  • Particle Size Distributionmodel
  • Residual Solventmodel